1. Home
  2. TUSK vs INO Comparison

TUSK vs INO Comparison

Compare TUSK & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mammoth Energy Services Inc.

TUSK

Mammoth Energy Services Inc.

HOLD

Current Price

$3.16

Market Cap

137.3M

Sector

Energy

ML Signal

HOLD

Logo Inovio Pharmaceuticals Inc.

INO

Inovio Pharmaceuticals Inc.

HOLD

Current Price

$1.25

Market Cap

118.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TUSK
INO
Founded
2014
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
137.3M
118.9M
IPO Year
2016
1999

Fundamental Metrics

Financial Performance
Metric
TUSK
INO
Price
$3.16
$1.25
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$6.75
AVG Volume (30 Days)
102.0K
3.2M
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
102.32
54.18
EPS
0.09
N/A
Revenue
$44,292,000.00
$42,220,086.00
Revenue This Year
$383.90
$20,156.19
Revenue Next Year
N/A
$421.95
P/E Ratio
$35.78
N/A
Revenue Growth
N/A
19.37
52 Week Low
$1.72
$0.56
52 Week High
$3.92
$2.72

Technical Indicators

Market Signals
Indicator
TUSK
INO
Relative Strength Index (RSI) 54.05 53.35
Support Level $2.98 $1.22
Resistance Level $3.32 $1.24
Average True Range (ATR) 0.12 0.09
MACD -0.01 -0.02
Stochastic Oscillator 65.67 43.24

Price Performance

Historical Comparison
TUSK
INO

About TUSK Mammoth Energy Services Inc.

Mammoth Energy Services Inc is an integrated energy services company engaged in providing products and services to enable the exploration and development of North American onshore unconventional oil and natural gas reserves as well as the construction and repair of the electric grid for private utilities, public investor-owned utilities, and co-operative utilities through infrastructure services businesses. The company had three reportable segments, which includes rental services, infrastructure services, natural sand proppant services, accommodation services, and drilling services.

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.

Share on Social Networks: